• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 17th October 2016

OHE at the EuroQol Plenary Meeting 2016

OHE’s Amanda Cole, Nancy Devlin, Yan Feng, Mike Herdman and Koonal Shah all contributed to the 33rd Plenary Meeting of the EuroQol Group in Berlin. The EuroQol Group, founded in 1987, is a global network of experts that initiated and…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

OHE’s Amanda Cole, Nancy Devlin, Yan Feng, Mike Herdman and Koonal Shah all contributed to the 33rd Plenary Meeting of the EuroQol Group in Berlin.

The EuroQol Group, founded in 1987, is a global network of experts that initiated and continues to develop the EQ-5D, a generic measure of health outcome. The 33rd Plenary Meeting of the EuroQol Group took place in Berlin on 15th and 16th September 2016. The Scientific Programme was chaired by Anna Krabbe-Lugnér and OHE’s Koonal Shah.

The annual EuroQol Plenary Meeting largely follows a discussant format whereby papers were pre-circulated to participants and presented by discussants rather than by authors. OHE researchers played an active role in both the presentation and discussion of papers.

Amanda Cole presented a paper assessing an alternative means of presenting health states in valuation exercises, by showing each health state within the context of the EQ-5D questionnaire completed by patients. The paper was co-authored by OHE’s Nancy Devlin, Yan Feng and Koonal Shah, and Brendan Mulhern of the University of Technology Sydney. The paper was discussed by Richard Noman.

Yan Feng also co-authored a paper reporting the exploration of ‘non-iterative time trade-off’, an innovative method developed to overcome some of the biases and limitations of traditional stated preference techniques. The study was conducted in collaboration with researchers at the University of Sheffield. The paper was discussed by Kim Rand-Hendriksen.

Another novel valuation method – ‘personal utility functions’ was featured in a paper authored by Nancy Devlin and Koonal Shah, in collaboration with Brendan Mulhern, Krystallia Pantiri and Ben van Hout. This approach has been featured in a previous OHE blog. In contrast to other approaches to valuing quality of life, this method uses a series of tasks designed to help participants to construct their own preferences, with a focus on deliberation and reflection. The approach includes an innovative way of establishing each individual’s personal anchor at 0. The paper was discussed by Kristina Ludwig.

Finally, Mike Herdman discussed a paper by Paul Kind on the future role of the three-level version of the EQ-5D instrument.

Full list of Plenary papers (all work-in-progress) with OHE authors:

  • Cole, A., Shah, K., Mulhern, B., Feng, Y. and Devlin, N., 2016. Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment. Paper presented at the 33rd EuroQol Plenary Meeting. Berlin. 15-16 September.
  • Devlin, N., Shah, K., Mulhern, B., Pantiri, K., van Hout, B., 2016. Modelling personal utility function-based value sets for EQ-5D. Paper presented at the 33rd EuroQol Plenary Meeting. Berlin. 15-16 September.
  • Feng, Y., Hole, A.R., Karimi, M., Tsuchiya, A. and van Hout, B., 2016. An exploration of the non-iterative time trade off: a paper from the ENITTO project. Paper presented at the 33rd EuroQol Plenary Meeting. Berlin. 15-16 September.
  • Viney, R., Mulhern, B., Norman, R., Shah, K., Bansback, N. and Longworth, L., 2016. Using DCE with duration to value EQ-5D-5L: Investigating task presentation. Paper presented at the 33rd EuroQol Plenary Meeting. Berlin. 15-16 September.

For more information about OHE’s programme of EuroQol-related research, please contact Nancy Devlin or Koonal Shah.

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Spotlight on OHE

Related News

  • News
  • November 2021

Opportunity Cost in Health Care: a Favourite Research Topic for OHE

Read more
  • News
  • May 2020

OHE Awarded Independent Research Organisation (IRO) Status by UKRI

Read more
  • News
  • February 2019

OHE Response to Public Consultation on NICE Principles

Read more
  • News
  • December 2018

OHE Achievements in 2018

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!